Analysts’ Viewpoint on Market Scenario
The synthetic biology market is growing at a rapid pace owing to the increase in demand for renewable fuel and bio-based chemicals; and inexpensive drugs and vaccines, which utilize synthetic biology techniques and products.
Additionally, participation of various organizations, such as BioBricks, DIYbio, and SynBERC, in the development of synthetic biology is expected to augment the global market during the forecast period.
Rise in advancements in synthetic biology and increase in demand for genetically modified crops due to surging population are also driving the global market. Companies operating in the market are focusing on innovation in the field of synthetic biology, such as cell free synthetic biology, to enhance their revenue streams.
Synthetic biology is a branch of science that deals with the re-engineering of organisms for useful purpose by transforming them into new possibilities. Synthetic biologists and key players across the world are harnessing the power of nature to solve problems in medicine, manufacturing, and agriculture.
Synthetic biology projects often aim to redesign organisms to make a substance, such as a drug or fuel, or acquire a new ability such as sensing something in the environment. Microorganisms used for bioremediation, rice modified to produce beta-carotene, and yeast modified to produce rose oil are some examples of synthetic biology.
Molecular genetics has become an integral part of biomedical science and clinical practice, having major implications in deciphering the pathogenesis and progression of disease, identifying diagnostic markers & prognosis, and designing better targeted treatments. Synthetic biology in medicine plays an important role in the Request a sample to get extensive insights into the Synthetic Biology Market
Synthetic biology is one of the solutions to reduce the risk of antibiotic-resistant microorganisms, which is a significant threat to drug development organizations. Manufacturers are applying synthetic biology to drug and vaccine development, as it is a process in which man-made biological materials are produced using biological devices and systems.
Synthetic biology is a process widely accepted by companies for the production of innovative and personalized drugs (drugs and vaccines). In 2014, the Massachusetts Institute of Technology (MIT) partnered with Pfizer to develop personalized and innovative drugs. Rise in prevalence of infectious diseases is driving the global market share of synthetic biology .
Infectious diseases such as H1N1, H1N5, and dengue fever are rampant among the population, and individualized and innovative treatments (drugs or vaccines) are needed to overcome them. Therefore, pharmaceutical companies have changed/adopted synthetic biology processes to recognize and improve the treatment of a particular disease/disorder. The global market trends indicate significant growth related to treatment enhancement.
Synthetic biology uses gene synthesis and DNA sequencing at a basic level to perform advanced experiments. Rapid progress has been made in the field of molecular biotechnology such as FISH, PCR, and aCGH. Advent of these innovative technologies enables experts to detect genetic anomalies and hidden chromosomal aberrations at an early stage of a disease. The FISH technique detects changes in chromosome number and structure.
PCR is a revolutionary sequencing method that can generate millions of DNA in a short time. The results obtained from this technique help doctors to decide what type of treatment is needed for a patient and monitor him or her during treatment selection. Array CGH is another molecular biology technique, which is widely used for clinical research in constitutional cytogenetics, rare diseases, cancer, and reproductive health.
aCGH provides high-resolution, genome-wide analysis for the detection of chromosome-wide aneuploidies, microsatellite deletions, and single exon-resolution duplication and replication neutral events such as loss of heterozygosity (LoH) and uniparental disomy (UPD). Rapid advancements in molecular biology enable researchers to find an effective result within a short time. Thus, advancement in molecular biology is driving the global market size of synthetic biology.
In terms of product type, the global market has been bifurcated into core products and enabling products. The core products segment has been classified into synthetic DNA, synthetic genes, synthetic cells, synthetic clones XNA & chassis organisms, and others.
The synthetic DNA sub-segment dominated the core products segment in 2021. Core products include a range of products that provide superior consumer benefits and satisfaction. These are tools designed primarily for high level synthesis products.
Synthetic DNA can bring out the functions of cells by artificially building them into existing DNA. These DNAs are injected directly into the cell nucleus to build a synthetic organism with the desired functionality. Synthetic genes are generated artificially for the development of economic genes that satisfy specific needs of consumers. These genes are produced in laboratories or clinics using artificial gene synthesis to modify the sequences of genes.
Advancement in synthetic biology and introduction of advanced technologies in the field of genetic, biology, engineering and computer sciences are augmenting the synthetic DNA sub-segment.
Based on technology, the global market has been classified into genome engineering, DNA sequencing, bioinformatics, biological components & integrated systems, microfluides, nanotechnology, and others. The genome engineering segment held major share of the global market in 2021. Genome engineering can be used to modify genetic foods, gene cloning, and gene therapy. Furthermore, the technique could be used in defeating various diseases.
Based on application, the global market has been divided into healthcare, chemicals, agriculture, and others. The healthcare segment accounted for the largest share of the global market in 2021.
This can be ascribed to the increase in utilization of synthetic biology technique to produce drugs and vaccines at lower cost. furthermore, the commercial availability of synthetic DNA and synthetic genes is driving the healthcare segment.
According to the market research analysis, Europe accounted for major share of the global market in 2021. This can be ascribed to consistent efforts by the European Union (EU) toward the development of synthetic biology in the region. Increase in application of synthetic biology techniques in the field of energy, health, environment, and other areas is driving the market in Europe.
The European Commission has provided funding for an initiative on New and Emerging Technologies (NEST) within the 6th Framework Programme (FP6). This initial funding was intended to encourage synthetic biology research in Europe that later would be supported by local funding agencies.
Additional investment came as part of the Horizon 2020 Programme, which ran from 2014 to 2020, offering a total of 21 grants focused on synthetic biology. Thus, rigorous efforts of these organizations is likely to provide a strong platform for the development of synthetic biology in Europe.
North America held the second-largest share of the global market in 2021. Increase in scientific research and novel technologies that could expand the scope for the development of synthetic biology is propelling the market in the region. Synthetic biology is rapidly growing in scientific and innovative sectors owing to its potential impact on health, environment, security, and human rights.
The global market is consolidated, with presence of a small number of large companies. Majority of the companies are investing significantly in research and development activities, primarily to introduce environmentally-friendly products. Expansion of product portfolio and mergers & acquisitions are key strategies adopted by major players.
Leading players in the global synthetic biology market are Bristol-Myers Squibb, Gevo, Inc., Life Technologies, DSM, DuPont, Inc., Genomatica, Inc., LS9, Inc., Amyris, Inc., Codexis, Inc., Twist Bioscience, Ginkgo Bioworks, GenScript, Insitro, ElevateBio, and Precigen, Inc.
Each of these players has been profiled in market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Market Size Value in 2021 | US$ 10.7 Bn |
| Market Forecast Value in 2031 | More than US$ 74.7 Bn |
| Growth Rate (CAGR) | 21.3% |
| Forecast Period | 2022-2031 |
| Historical Data Available for | 2017-2020 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis at global as well as regional level. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
The global synthetic biology market was valued at US$ 10.7 Bn in 2021
The global synthetic biology market is projected to reach more than US$ 74.7 Bn by 2031
The global synthetic biology market advanced at a CAGR of 21.7% from 2017 to 2021
The global synthetic biology market is anticipated to advance at a CAGR of 21.3% from 2022 to 2031
Rise in demand for improved drugs & vaccines and advancement in molecular biology
Europe is expected to account for the largest share of the global market during the forecast period
Bristol-Myers Squibb, Gevo, Inc., Life Technologies, DSM, DuPont, Inc., Genomatica, Inc., LS9, Inc., Amyris, Inc., Codexis, Inc., Twist Bioscience, Ginkgo Bioworks, GenScript, Insitro, ElevateBio, and Precigen, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Synthetic Biology Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Synthetic Biology Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key industry events (mergers & acquisitions, product launch, partnerships, etc.)
5.2. Technological advancements
5.3. Government funding & funding deals
5.4. Covid-19 Pandemic impact on the Industry
6. Global Synthetic Biology Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017-2031
6.3.1. Core Products
6.3.1.1. Synthetic DNA
6.3.1.2. Synthetic Genes
6.3.1.3. Synthetic Clones
6.3.1.4. Synthetic Cells
6.3.1.5. XNA & Chassis Organisms
6.3.1.6. Others
6.3.2. Enabling Products
6.3.2.1. DNA Synthesis
6.3.2.2. Oligonucleotide Synthesis
6.4. Market Attractiveness Analysis, by Product
7. Global Synthetic Biology Market Analysis and Forecast, by Technology
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017-2031
7.3.1. Genome Engineering
7.3.2. DNA Sequencing
7.3.3. Bioinformatics
7.3.4. Biological Components & Integrated Systems
7.3.5. Nanotechnology
7.3.6. Others
7.4. Market Attractiveness Analysis, by Technology
8. Global Synthetic Biology Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Application, 2017-2031
8.3.1. Healthcare
8.3.2. Chemicals
8.3.3. Agriculture
8.3.4. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Synthetic Biology Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Synthetic Biology Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017-2031
10.2.1. Core Products
10.2.1.1. Synthetic DNA
10.2.1.2. Synthetic Genes
10.2.1.3. Synthetic Clones
10.2.1.4. Synthetic Cells
10.2.1.5. XNA & Chassis Organisms
10.2.1.6. Others
10.2.2. Enabling Products
10.2.2.1. DNA Synthesis
10.2.2.2. Oligonucleotide Synthesis
10.3. Market Value Forecast, by Technology, 2017-2031
10.3.1. Genome Engineering
10.3.2. DNA Sequencing
10.3.3. Bioinformatics
10.3.4. Biological Components & Integrated Systems
10.3.5. Nanotechnology
10.3.6. Others
10.4. Market Value Forecast, by Application, 2017-2031
10.4.1. Healthcare
10.4.2. Chemicals
10.4.3. Agriculture
10.4.4. Others
10.5. Market Value Forecast, by Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Technology
10.6.3. By Application
10.6.4. By Country
11. Europe Synthetic Biology Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017-2031
11.2.1. Core Products
11.2.1.1. Synthetic DNA
11.2.1.2. Synthetic Genes
11.2.1.3. Synthetic Clones
11.2.1.4. Synthetic Cells
11.2.1.5. XNA & Chassis Organisms
11.2.1.6. Others
11.2.2. Enabling Products
11.2.2.1. DNA Synthesis
11.2.2.2. Oligonucleotide Synthesis
11.3. Market Value Forecast, by Technology, 2017-2031
11.3.1. Genome Engineering
11.3.2. DNA Synthesis
11.3.3. Bioinformatics
11.3.4. Biological Components & Integrated Systems
11.3.5. Nanotechnology
11.3.6. Others
11.4. Market Value Forecast, by Application, 2017-2031
11.4.1. Healthcare
11.4.2. Chemicals
11.4.3. Agriculture
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Technology
11.6.3. By Application
11.6.4. By Country/Sub-region
12. Asia Pacific Synthetic Biology Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017-2031
12.2.1. Core Products
12.2.1.1. Synthetic DNA
12.2.1.2. Synthetic Genes
12.2.1.3. Synthetic Clones
12.2.1.4. Synthetic Cells
12.2.1.5. XNA & Chassis Organisms
12.2.1.6. Others
12.2.2. Enabling Products
12.2.2.1. DNA Synthesis
12.2.2.2. Oligonucleotide Synthesis
12.3. Market Value Forecast, by Technology, 2017-2031
12.3.1. Genome Engineering
12.3.2. DNA Sequencing
12.3.3. Bioinformatics
12.3.4. Biological Components & Integrated Systems
12.3.5. Nanotechnology
12.3.6. Others
12.4. Market Value Forecast, by Application, 2017-2031
12.4.1. Healthcare
12.4.2. Chemicals
12.4.3. Agriculture
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Technology
12.6.3. By Application
12.6.4. By Country/Sub-region
13. Latin America Synthetic Biology Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017-2031
13.2.1. Core Products
13.2.1.1. Synthetic DNA
13.2.1.2. Synthetic Genes
13.2.1.3. Synthetic Clones
13.2.1.4. Synthetic Cells
13.2.1.5. XNA & Chassis Organisms
13.2.1.6. Others
13.2.2. Enabling Products
13.2.2.1. DNA Synthesis
13.2.2.2. Oligonucleotide Synthesis
13.3. Market Value Forecast, by Technology, 2017-2031
13.3.1. Genome Engineering
13.3.2. DNA Sequencing
13.3.3. Bioinformatics
13.3.4. Biological Components & Integrated Systems
13.3.5. Nanotechnology
13.3.6. Others
13.4. Market Value Forecast, by Application, 2017-2031
13.4.1. Healthcare
13.4.2. Chemicals
13.4.3. Agriculture
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Technology
13.6.3. By Application
13.6.4. By Country/Sub-region
14. Middle East & Africa Synthetic Biology Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017-2031
14.2.1. Core Products
14.2.1.1. Synthetic DNA
14.2.1.2. Synthetic Genes
14.2.1.3. Synthetic Clones
14.2.1.4. Synthetic Cells
14.2.1.5. XNA & Chassis Organisms
14.2.1.6. Others
14.2.2. Enabling Products
14.2.2.1. DNA Synthesis
14.2.2.2. Oligonucleotide Synthesis
14.3. Market Value Forecast, by Technology, 2017-2031
14.3.1. Genome Engineering
14.3.2. DNA Synthesis
14.3.3. Bioinformatics
14.3.4. Biological Components & Integrated Systems
14.3.5. Nanotechnology
14.3.6. Others
14.4. Market Value Forecast, by Application, 2017-2031
14.4.1. Healthcare
14.4.2. Chemicals
14.4.3. Agriculture
14.4.4. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Technology
14.6.3. By Application
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share/Ranking Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. Bristol-Myers Squibb
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Strategic Overview
15.3.2. Gevo, Inc.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Strategic Overview
15.3.3. Life Technologies
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Strategic Overview
15.3.4. DSM
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Strategic Overview
15.3.5. DuPont, Inc.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Strategic Overview
15.3.6. Genomatica, Inc.
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Strategic Overview
15.3.7. LS9, Inc.
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Strategic Overview
15.3.8. Amyris, Inc.
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Strategic Overview
15.3.9. Codexis, Inc.
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Strategic Overview
15.3.10. Twist Bioscience
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Strategic Overview
15.3.11. Ginkgo Bioworks
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Strategic Overview
15.3.12. GenScript
15.3.12.1. Company Overview
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Strategic Overview
15.3.13. Insitro
15.3.13.1. Company Overview
15.3.13.2. Product Portfolio
15.3.13.3. SWOT Analysis
15.3.13.4. Strategic Overview
15.3.14. ElevateBio
15.3.14.1. Company Overview
15.3.14.2. Product Portfolio
15.3.14.3. SWOT Analysis
15.3.14.4. Strategic Overview
15.3.15. Precigen, Inc.
15.3.15.1. Company Overview
15.3.15.2. Product Portfolio
15.3.15.3. SWOT Analysis
15.3.15.4. Strategic Overview
List of Tables
Table 01: Global Synthetic Biology Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 02: Synthetic Biology Market Value (US$ Mn) Forecast, by 2017-2031, by Technology
Table 03: Global Synthetic Biology Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 04: Global Synthetic Biology Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 05: North America Synthetic Biology Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 06: North America Synthetic Biology Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 07: North America Synthetic Biology Market Value (US$ Mn) Forecast, by Technology, 2017-2031
Table 08: North America Synthetic Biology Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 09: Europe Synthetic Biology Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031
Table 10: Europe Synthetic Biology Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 11: Europe Synthetic Biology Market Value (US$ Mn) Forecast, by Technology, 2017-2031
Table 12: Europe Synthetic Biology Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 13: Asia Pacific Synthetic Biology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 14: Asia Pacific Synthetic Biology Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 15: Asia Pacific Synthetic Biology Market Value (US$ Mn) Forecast, by Technology, 2017-2031
Table 16: Asia Pacific Synthetic Biology Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 17: Latin America Synthetic Biology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 18: Latin America Synthetic Biology Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 19: Latin America Synthetic Biology Market Value (US$ Mn) Forecast, by Technology, 2017-2031
Table 20: Latin America Synthetic Biology Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 21: Middle East & Africa Synthetic Biology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Middle East & Africa Synthetic Biology Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 23: Middle East & Africa Synthetic Biology Market Value (US$ Mn) Forecast, by Technology, 2017-2031
Table 24: Middle East & Africa Synthetic Biology Market Value (US$ Mn) Forecast, by Application, 2017-2031
List of Figures
Figure 01: Global Synthetic Biology Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global Synthetic Biology Market Value Share, by Product, 2021
Figure 03: Global Synthetic Biology Market Value Share, by Technology, 2021
Figure 04: Global Synthetic Biology Market Value Share, by Application, 2021
Figure 05: Global Synthetic Biology Market Value Share Analysis, by Product, 2021 and 2031
Figure 06: Global Synthetic Biology Market Attractiveness Analysis, by Product, 2022-2031
Figure 07: Global Synthetic Biology Market Value (US$ Mn), by Core Products, 2017-2031
Figure 08: Global Synthetic Biology Market Value (US$ Mn), by Enabling Products, 2017-2031
Figure 09: Global Synthetic Biology Market Value Share Analysis, by Technology, 2021 and 2031
Figure 10: Global Synthetic Biology Market Attractiveness Analysis, by Technology, 2022-2031
Figure 11: Global Synthetic Biology Market Value Share Analysis, by Application, 2021 and 2031
Figure 12: Global Synthetic Biology Market Attractiveness Analysis, by Application, 2022-2031
Figure 13: Global Synthetic Biology Market Value Share Analysis, by Region, 2021 and 2031
Figure 14: Global Synthetic Biology Market Attractiveness Analysis, by Region, 2022-2031
Figure 15: North America Synthetic Biology Market Value (US$ Mn) Forecast, 2017-2031
Figure 16: North America Synthetic Biology Market Value Share Analysis, by Country, 2021 and 2031
Figure 17: North America Synthetic Biology Market Attractiveness Analysis, by Country, 2022-2031
Figure 18: North America Synthetic Biology Market Value Share Analysis, by Product, 2021 and 2031
Figure 19: North America Synthetic Biology Market Attractiveness Analysis, by Product, 2022-2031
Figure 20: North America Synthetic Biology Market Value Share Analysis, by Technology, 2021 and 2031
Figure 21: North America Synthetic Biology Market Attractiveness Analysis, by Technology, 2022-2031
Figure 22: North America Synthetic Biology Market Value Share Analysis, by Application, 2021 and 2031
Figure 23: North America Synthetic Biology Market Attractiveness Analysis, by Application, 2022-2031
Figure 24: Europe Synthetic Biology Market Value (US$ Mn) Forecast, 2017-2031
Figure 25: Europe Synthetic Biology Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 26: Europe Synthetic Biology Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 27: Europe Synthetic Biology Market Value Share Analysis, by Product, 2021 and 2031
Figure 28: Europe Synthetic Biology Market Attractiveness Analysis, by Product, 2022-2031
Figure 29: Europe Synthetic Biology Market Value Share Analysis, by Technology, 2021 and 2031
Figure 30: Europe Synthetic Biology Market Attractiveness Analysis, by Technology, 2022-2031
Figure 31: Europe Synthetic Biology Market Value Share Analysis, by Application, 2021 and 2031
Figure 32: Europe Synthetic Biology Market Attractiveness Analysis, by Application, 2022-2031
Figure 33: Asia Pacific Synthetic Biology Market Value (US$ Mn) Forecast, 2017-2031
Figure 34: Asia Pacific Synthetic Biology Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 35: Asia Pacific Synthetic Biology Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 36: Asia Pacific Synthetic Biology Market Value Share Analysis, by Product, 2021 and 2031
Figure 37: Asia Pacific Synthetic Biology Market Attractiveness Analysis, by Product, 2022-2031
Figure 38: Asia Pacific Synthetic Biology Market Value Share Analysis, by Technology, 2021 and 2031
Figure 39: Asia Pacific Synthetic Biology Market Attractiveness Analysis, by Technology, 2022-2031
Figure 40: Asia Pacific Synthetic Biology Market Value Share Analysis, by Application, 2021 and 2031
Figure 41: Asia Pacific Synthetic Biology Market Attractiveness Analysis, by Application, 2022-2031
Figure 42: Latin America Synthetic Biology Market Value (US$ Mn) Forecast, 2017-2031
Figure 43: Latin America Synthetic Biology Market Value Share Analysis, by Country/Sub-Region, 2021 and 2031
Figure 44: Latin America Synthetic Biology Market Attractiveness Analysis, by Country/Sub-Region, 2021-2031
Figure 45: Latin America Synthetic Biology Market Value Share Analysis, by Product, 2021 and 2031
Figure 46: Latin America Synthetic Biology Market Attractiveness Analysis, by Product, 2022-2031
Figure 47: Latin America Synthetic Biology Market Value Share Analysis, by Technology, 2021 and 2031
Figure 48: Latin America Synthetic Biology Market Attractiveness Analysis, by Technology, 2022-2031
Figure 49: Latin America Synthetic Biology Market Value Share Analysis, by Application, 2021 and 2031
Figure 50: Latin America Synthetic Biology Market Attractiveness Analysis, by Application, 2022-2031
Figure 51: Middle East & Africa Synthetic Biology Market Value (US$ Mn) Forecast, 2017-2031
Figure 52: Middle East & Africa Synthetic Biology Market Value Share Analysis, by Country/Sub-Region, 2021 and 2031
Figure 53: Middle East & Africa Synthetic Biology Market Attractiveness Analysis, by Country/Sub-Region, 2021-2031
Figure 54: Middle East & Africa Synthetic Biology Market Value Share Analysis, by Product, 2021 and 2031
Figure 55: Middle East & Africa Synthetic Biology Market Attractiveness Analysis, by Product, 2022-2031
Figure 56: Middle East & Africa Synthetic Biology Market Value Share Analysis, by Technology, 2021 and 2031
Figure 57: Middle East & Africa Synthetic Biology Market Attractiveness Analysis, by Technology, 2022-2031
Figure 58: Middle East & Africa Synthetic Biology Market Value Share Analysis, by Application, 2021 and 2031
Figure 59: Middle East & Africa Synthetic Biology Market Attractiveness Analysis, by Application, 2022-2031
Figure 60: Company Share Analysis, 2021
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Synthetic Biology Market
